DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

NCT00273338 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Stopped DSMB

Conditions

Prostate Cancer

Interventions

DRUG: calcitriol
DRUG: docetaxel

Sponsor

Novacea